Filing Details
- Accession Number:
- 0001209191-24-004016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-27 17:03:15
- Reporting Period:
- 2024-02-23
- Accepted Time:
- 2024-02-27 17:03:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1260990 | Oncternal Therapeutics Inc. | ONCT | Pharmaceutical Preparations (2834) | CA |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1024004 | F David Hale | 12230 El Camino Real, Suite 230 San Diego CA 92130 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-23 | 714 | $9.04 | 714 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-02-23 | 266 | $9.04 | 29,673 | No | 4 | P | Indirect | By Hale BioPharma Ventures, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | By Hale BioPharma Ventures, LLC |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 917 | Indirect | By Hale Trading Company |
Footnotes
- The shares of common stock were acquired directly from another director of the Issuer, Robert James Wills, in a private sale. The price per share was based on the closing price of the Issuer's common stock on February 23, 2024.
Billionaire Hedge Funds
